Compare iShares Gold Trust (IAU) vs Ionis Pharmaceuticals Inc. Common Stock (IONS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Gold Trust vs Ionis Pharmaceuticals Inc. Common Stock — how do they compare? iShares Gold Trust trades at $78.13 (market cap $62.13B), while Ionis Pharmaceuticals Inc. Common Stock trades at $43.2 (market cap $7.04B). The key difference: iShares Gold Trust is far larger — about 8.8× Ionis Pharmaceuticals Inc. Common Stock's market cap, and iShares Gold Trust is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares Gold Trust for 51 Days and Ionis Pharmaceuticals Inc. Common Stock for 0 Days on average.
| IAU | IONS | |
|---|---|---|
Market Cap | $62.13B | $7.04B |
Volume | 3,713,095 | 2,977,440 |
Sector | Commodities - Metals/Agriculture | Health |
52-Week High | $101.57 | $86.50 |
52-Week Low | $74.21 | $42.38 |
Typical Hold Time | 51 Days | 0 Days |
Enterprise Value | — | $6.60B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IAU shares are trading at $78.25, down 0.11% with bearish technical signals dominating the short-term outlook. The stock faces pressure from rising Treasury yields and Federal Reserve rate uncertainty, though recent soft inflation data has provided some support. Technical indicators show selling pressure outweighing buying signals, with moving averages pointing downward and key resistance at $79.
The stock faces headwinds from monetary policy uncertainty and yield pressures, but potential exists if inflation concerns resurface. Key risks include continued rate hike expectations and dollar strength, while opportunities may emerge from safe-haven demand during market volatility. The technical setup suggests caution in the near term with support at $78.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares Gold Trust
IAU is a physically backed ETF that seeks to reflect the performance of the price of gold. It provides a convenient and liquid way for investors to include gold in their portfolios as a potential hedge.
Read more on IAU →About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →
